Literature DB >> 19494841

Chromosomal imbalances and partial uniparental disomies in primary central nervous system lymphoma.

H Schwindt1, I Vater, M Kreuz, M Montesinos-Rongen, A Brunn, J Richter, S Gesk, O Ammerpohl, O D Wiestler, D Hasenclever, M Deckert, R Siebert.   

Abstract

To determine the pattern of genetic alterations in primary central nervous system lymphomas (PCNSL), 19 PCNSL were studied by high-density single-nucleotide polymorphism arrays. Recurrent losses involved 6p21.32, 6q21, 8q12-12.2, 9p21.3, 3p14.2, 4q35.2, 10q23.21 and 12p13.2, whereas gains involved 18q21-23, 19q13.31, 19q13.43 and the entire chromosomes X and 12. Partial uniparental disomies (pUPDs) were identified in 6p and 9p21.3. These genomic alterations affected the HLA locus, the CDKN2A/p16, CDKN2B/p15 and MTAP, as well as the PRDM1, FAS, MALT1, and BCL2 genes. Increased methylation values of the CDKN2A/p16 promoter region were detected in 75% (6/8) PCNSL. Gene expression profiling showed 4/21 (20%) minimal common regions of imbalances to be associated with a differential mRNA expression affecting the FAS, STAT6, CD27, ARHGEF6 and SEPT6 genes. Collectively, this study unraveled novel genomic imbalances and pUPD with a high resolution in PCNSL and identified target genes of potential relevance in the pathogenesis of this lymphoma entity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19494841     DOI: 10.1038/leu.2009.120

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  31 in total

1.  Array-based DNA methylation profiling of primary lymphomas of the central nervous system.

Authors:  Julia Richter; Ole Ammerpohl; José I Martín-Subero; Manuel Montesinos-Rongen; Marina Bibikova; Eliza Wickham-Garcia; Otmar D Wiestler; Martina Deckert; Reiner Siebert
Journal:  BMC Cancer       Date:  2009-12-21       Impact factor: 4.430

2.  Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas.

Authors:  Esteban Braggio; Scott Van Wier; Juhi Ojha; Ellen McPhail; Yan W Asmann; Jan Egan; Jackline Ayres da Silva; David Schiff; M Beatriz Lopes; Paul A Decker; Riccardo Valdez; Raoul Tibes; Bruce Eckloff; Thomas E Witzig; A Keith Stewart; Rafael Fonseca; Brian Patrick O'Neill
Journal:  Clin Cancer Res       Date:  2015-05-19       Impact factor: 12.531

3.  Differential expression of Toll-like receptor (TLR) and B cell receptor (BCR) signaling molecules in primary diffuse large B-cell lymphoma of the central nervous system.

Authors:  Ariz Akhter; Noraidah Masir; Ghaleb Elyamany; Kean-Chang Phang; Etienne Mahe; Ali Matar Al-Zahrani; Meer-Taher Shabani-Rad; Douglas Allan Stewart; Adnan Mansoor
Journal:  J Neurooncol       Date:  2014-11-13       Impact factor: 4.130

Review 4.  New approaches in primary central nervous system lymphoma.

Authors:  Eleanor Fraser; Katherine Gruenberg; James L Rubenstein
Journal:  Chin Clin Oncol       Date:  2015-03

Review 5.  Primary central nervous system lymphoma: essential points in diagnosis and management.

Authors:  Semra Paydas
Journal:  Med Oncol       Date:  2017-03-17       Impact factor: 3.064

Review 6.  [Differential diagnosis of lymphoid infiltrates in the central nervous system: experience of the Network Lymphomas and Lymphomatoid Lesions in the Nervous System].

Authors:  W Brück; A Brunn; W Klapper; T Kuhlmann; I Metz; W Paulus; M Deckert
Journal:  Pathologe       Date:  2013-05       Impact factor: 1.011

7.  Primary central nervous system lymphomas: a validation study of array-based comparative genomic hybridization in formalin-fixed paraffin-embedded tumor specimens.

Authors:  Esteban Braggio; Ellen Remstein McPhail; William Macon; M Beatriz Lopes; David Schiff; Mark Law; Stephanie Fink; Debra Sprau; Caterina Giannini; Ahmet Dogan; Rafael Fonseca; Brian Patrick O'Neill
Journal:  Clin Cancer Res       Date:  2011-05-11       Impact factor: 12.531

8.  The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing.

Authors:  I Vater; M Montesinos-Rongen; M Schlesner; A Haake; F Purschke; R Sprute; N Mettenmeyer; I Nazzal; I Nagel; J Gutwein; J Richter; I Buchhalter; R B Russell; O D Wiestler; R Eils; M Deckert; R Siebert
Journal:  Leukemia       Date:  2014-09-05       Impact factor: 11.528

9.  Plasmablastic lymphoma phenotype is determined by genetic alterations in MYC and PRDM1.

Authors:  Santiago Montes-Moreno; Nerea Martinez-Magunacelaya; Tomás Zecchini-Barrese; Sonia Gonzalez de Villambrosía; Emma Linares; Tamara Ranchal; María Rodriguez-Pinilla; Ana Batlle; Laura Cereceda-Company; Jose Bernardo Revert-Arce; Carmen Almaraz; Miguel A Piris
Journal:  Mod Pathol       Date:  2016-09-30       Impact factor: 7.842

10.  EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity.

Authors:  M K Gandhi; T Hoang; S C Law; S Brosda; K O'Rourke; J W D Tobin; F Vari; V Murigneux; L Fink; J Gunawardana; C Gould; H Oey; K Bednarska; S Delecluse; R U Trappe; L Merida de Long; M B Sabdia; G Bhagat; G Hapgood; E Blyth; L Clancy; J Wight; E Hawkes; L M Rimsza; A Maguire; K Bojarczuk; B Chapuy; C Keane
Journal:  Blood       Date:  2021-03-18       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.